Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select ...

Bausch+Lomb ... listing Bausch + Lomb in 2022 but struggled to execute the full separation due to concerns about solvency after the split. The world’s largest contact lens supplier, valued ...

Larry Biegelsen, an analyst from Wells Fargo, assigned the Buy rating on Bausch + Lomb Corporation (BLCO ... of more than 400 products includes contact lenses, lens care products, eye care ...

Blackstone, Advent International and TPG are among a long list of private equity firms studying bids for Bausch + Lomb, according ... comes from sales of contact lenses and dry eye drugs Xiidra ...

the contact lens maker’s enterprise value stood slightly above $10B, including debt, as of Friday's market close. Bausch Health (BHC) retained an 88% stake in Bausch + Lomb (BLCO) when the ...

Bausch + Lomb is one of the leading contact-lens suppliers in the world. Bausch Health and Goldman Sachs declined to comment to the FT. Bausch + Lomb is headed by Brent Saunders, a longtime ...

Company operates a contact lens manufacturing facility in Waterford where approximately 1,500 people are employed. Separate from the refinancing option, Bausch + Lomb is exploring a sale of itself ...

Edward Bausch transformed the world of optics with groundbreaking inventions like the iris diaphragm shutter and advanced ...